HRS 22: Complications Among S-ICD Vs TV-ICD Recipients: The ATLAS Trial

  • Jeff Healey
  • 06.07.22

In this short interview, Dr Jeff Healey (McMaster University, Hamilton, CA) talks about the key data from the ATLAS (Avoid Transvenous Leads in Appropriate Subjects) trial (NCT02881255).
The aim of the study was to compare standard, single chamber transvenous ICD (TV-ICD) to sub-cutaneous ICD (S-ICD)(Boston Scientific EMBLEM) in occurrence of perioperative and long term device related complications and failed appropriate clinical shocks and arrhythmic death.

Discussion Points
Trial Backgound
Study Design & Eligibility Criteria
Key Findings
When to Select S-ICD Over TV-ICD
Implications for Practice & for Guidelines
Next Steps

Recorded on-site at Heart Rhythm 2022, San Francisco.